Navigating the tense, complex oncology market
Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension
2012 site selection report
Biopharma remains a bright spot in US and international economic activity, even while the overall outlook remains cloudy
Healthcare's 'third place--patient-centered healthcare--is life sciences' future business focus, says E&Y
Latest annual Progressions report highlights the shift to healthy behaviors
Supply chains for a patient-centric world
Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models
FTC Approves Express Scripts/Medco Merger: Excerpts
Merger is not expected to affect specialty-distribution agreements negatively
Jobs and biopharma
Ten-year BLS projection sees a healthy industry ahead
US market for pharmaceuticals was $320 billion in 2011, says IMS Institute
Patient office visits, prescription usage continued to decline
NEHI: Medication adherence needs better coordination among stakeholders
Pharma industry serves best as underwriter of healthcare providers' efforts
Some good news on drug shortage--finally
Covis Pharmaceuticals' business model is to acquire distribution rights to low-volume drugs
A scientific approach to site selection
Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes
Compliance, technology energize the master-data management business
Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever
